The risk of hypoparathyroidism after central compartment lymph node dissection in the surgical treatment of pT1, N0 thyroid papillary carcinoma.

MLA

Aydin, O. U., et al. “The Risk of Hypoparathyroidism after Central Compartment Lymph Node Dissection in the Surgical Treatment of PT1, N0 Thyroid Papillary Carcinoma.” European Review for Medical & Pharmacological Sciences, vol. 20, no. 9, May 2016, pp. 1781–87. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=115735668&authtype=sso&custid=ns315887.

APA

Aydin, O. U., Soylu, L., Ozbas, S., Ilgan, S., Bilezikci, B., Gursoy, A., Sengezer, T., & Kocak, S. (2016). The risk of hypoparathyroidism after central compartment lymph node dissection in the surgical treatment of pT1, N0 thyroid papillary carcinoma. European Review for Medical & Pharmacological Sciences, 20(9), 1781–1787.

Chicago

Aydin, O.U., L. Soylu, S. Ozbas, S. Ilgan, B. Bilezikci, A. Gursoy, T. Sengezer, and S. Kocak. 2016. “The Risk of Hypoparathyroidism after Central Compartment Lymph Node Dissection in the Surgical Treatment of PT1, N0 Thyroid Papillary Carcinoma.” European Review for Medical & Pharmacological Sciences 20 (9): 1781–87. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=115735668&authtype=sso&custid=ns315887.